Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:48 PM
Ignite Modification Date: 2025-12-24 @ 11:48 PM
NCT ID: NCT06487351
Eligibility Criteria: Inclusion Criteria: Three types of participants will be included 1. Pharmacy interns: * Pharmacy intern (non-licensed individual undergoing training and preparations for licensure examination). * Currently registered as a regular student in the School of Pharmacy, Bouvé College of Health Sciences at Northeastern University, Boston, MA. * Doing the internship in pharmacies located in cities with the highest average annual rate of HIV infection diagnosis in Suffolk County, MA. * Experience with PrEP (counsel PrEP candidates, complete PrEP continuing education activity, or awareness with current CDC guidelines on PrEP use) OR willingness to prescribe PrEP in the future (will be measured with one Yes/No question: "Are you willing to prescribe PrEP in the future?) * Moderate to high preference for White people as measured by the Implicit Association Test. 2. Pharmacy managers * Defined as an individual designated by a pharmacy owner to manage a pharmacy. * Pharmacy managers of pharmacies located in the same areas described above. 3. Pharmacy policymaker defined as official employee of the Boards of Registration in Pharmacy whose role is directly related to community pharmacy practice (e.g., director of pharmacy compliance). Exclusion Criteria: Inability to provide consent (e.g., intoxication), unwillingness to provide consent
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT06487351
Study Brief:
Protocol Section: NCT06487351